Results 111 to 120 of about 1,935,200 (187)

Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey

International Journal of Medical Sciences, 2011
Background: Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease (CAD).
Davran Çiçek, Hasan Pekdemir, Cevahir Haberal, Nihat Kalay, Süleyman Binici, Hakan Altay, Haldun Müderrisoğlu
doaj  

Pharmaceutical aspects of drug eluting stents

, 2008
This review focuses on the pharmaceutical aspects of the development of drug eluting stents. It discusses the different processes that can be used to obtain a controlled release of a drug from the stent as well as the coatings therefore applied.
Van den Mooter, Guy, De Scheerder, I., Sohier, Jürgen, Deconinck, Eric   +3 more
core   +1 more source

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction [PDF]

, 2017
Aims To compare the efficacy and safety of drug-eluting stents vs. bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
Varricchio, Attilio, Pittl, Undine, Spaulding, Christian, Mehilli, Julinda, Kastrati, Adnan, Tierala, Ilkka, Menichelli, Maurizio, Seyfarth, Melchior, Suttorp, Maarten J., Violini, Roberto, Di Lorenzo, Emilio, Schömig, Albert, Laarman, Gerrit J., Varenne, Olivier, Dibra, Alban, Kaiser, Christoph, Valgimigli, Marco, Syvänne, Mikko, Dirksen, Maurits T., Percoco, Gianfranco   +19 more
core  

Novel drug-eluting stents in the treatment of de novo coronary lesions

, 2011
Davide Capodanno1,2, Fabio Dipasqua1, Corrado Tamburino1,21Department of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy; 2ETNA Foundation, Catania, ItalyAbstract: Due to safety concerns in recent years, much effort has been ...
Capodanno D, Dipasqua F, Tamburino C
core  

Differences in drug-eluting stents used in coronary artery disease

, 2011
The introduction of drug-eluting stents (DES) has improved the efficacy of percutaneous coronary intervention by addressing the issue of neointimal proliferation, a pathology contributing to restenosis.
Stathogiannis, K., Tsiamis, E., Stefanadis, C., Lerakis, S., Karanasos, A., Synetos, A., Toutouzas, K., Triantafyllou, G.   +7 more
core   +1 more source

Clinical Outcomes of Drug-Eluting Stents and Drug-Coated Balloons in Tortuous Small Coronary Lesions. [PDF]

Catheter Cardiovasc Interv
Ishio S, Nagasaka T, Taniuchi R, Amanai S, Ishibashi Y, Takama N, Ishii H.   +6 more
europepmc   +1 more source

A Comprehensive Numerical Simulation on the Safety and Efficacy of Circular-Versus Trapezoidal-Shaped Intravascular Drug-Eluting Stents. [PDF]

Int J Numer Method Biomed Eng
Saha R, Mandal AP.
europepmc   +1 more source

Two-Year Clinical Outcomes of Contemporary Drug-Eluting Stents Grouped by Eluted Limus Agent: A Retrospective Cohort Study. [PDF]

J Clin Med
Joo D, Byoun JT, Cho JY, Jo S, Yun KH.
europepmc   +1 more source

Drug-eluting stents

, 2006
Stent implantation was developed to overcome the acute recoil and high restenosis rate of balloon angioplasty, but resulted in the development of chronic in-stent restenosis related to specific factors regarding patient, stent, lesion and procedural ...
Vaina,Sophia, Serruys, PWJC (Patrick), García-García,Héctor M, Serruys,Patrick W, Garcia Garcia, Hector, Vaina, S (Sophia), Tsuchida,Keiichi, Tsuchida, K (Keiichi)   +7 more
core  

Regional Differences Between Drug-Coated Balloons and Drug-Eluting Stents in <i>De Novo</i> Coronary Disease. [PDF]

Cardiol Res
Dangol GMS, Le Q, Maharjan S, Schettino Samad N, Graff Caletti GC, da Costa MR, Cavalcanti Souza ME, Modi K.   +7 more
europepmc   +1 more source